SPHMMC and Hamlin Fistula Ethiopia Sign Agreement to Strengthen Maternal Health Care
St Paul’s Hospital Millennium Medical College (SPHMMC) and Hamlin Fistula Ethiopia have signed a Memorandum of Understanding (MoU) aimed at strengthening cooperation in maternal health services, research and specialised care in Ethiopia.
The agreement was signed by Dr Lemi Belay, Vice Provost for Academic and Medical Services at SPHMMC, and Dr Binyam, Chief Executive Officer and Medical Director of Hamlin Fistula Ethiopia.
Speaking at the signing ceremony, Dr Lemi Belay said the partnership would help expand access to high-quality specialised care and bring meaningful benefits to mothers and children. He added that the collaboration would strengthen the institutions’ capacity
St Paul’s Hospital Millennium Medical College (SPHMMC) and Hamlin Fistula Ethiopia have signed a Memorandum of Understanding (MoU) aimed at strengthening cooperation in maternal health services, research and specialised care in Ethiopia.
The agreement was signed by Dr Lemi Belay, Vice Provost for Academic and Medical Services at SPHMMC, and Dr Binyam, Chief Executive Officer and Medical Director of Hamlin Fistula Ethiopia.
Speaking at the signing ceremony, Dr Lemi Belay said the partnership would help expand access to high-quality specialised care and bring meaningful benefits to mothers and children. He added that the collaboration would strengthen the institutions’ capacity
Call for Application
Paul’s Hospital Millennium Medical College
Department of Oral and Maxillofacial Surgery
The Department of Oral and Maxillofacial Surgery hereby announces a new intake for eligible applicants.
Application dates: Up to January 30, 2025
Entrance Exam Date: February 6, 2025
Eligibility Criteria
Applicants must fulfill the following requirements:
Hold a first degree in Dental Medicine (DDS or DDM)
Have two (2) years or more of relevant work experience
Be in good physical and mental health
Age limit: 40 years and below
All applicants must pass the NGAT entrance examination
Applicants who have obtained a sponsorship letter from their employing institution are encouraged to apply
Application Procedure
Interested and eligible candidates are required to submit their application documents to the Department via email. mfd@sphmmc.edu.et
Paul’s Hospital Millennium Medical College
Department of Oral and Maxillofacial Surgery
The Department of Oral and Maxillofacial Surgery hereby announces a new intake for eligible applicants.
Application dates: Up to January 30, 2025
Entrance Exam Date: February 6, 2025
Eligibility Criteria
Applicants must fulfill the following requirements:
Hold a first degree in Dental Medicine (DDS or DDM)
Have two (2) years or more of relevant work experience
Be in good physical and mental health
Age limit: 40 years and below
All applicants must pass the NGAT entrance examination
Applicants who have obtained a sponsorship letter from their employing institution are encouraged to apply
Application Procedure
Interested and eligible candidates are required to submit their application documents to the Department via email. mfd@sphmmc.edu.et
Date-12/26/2025
Call for Application
St Paul’s Hospital Millennium Medical College, Department of Surgery planned to enroll fellow in Vascular and Endovascular Surgery fellowship program. So it is to invite interested surgeons to apply for the program.
Eligibility:
1. At least 2 years of service as a general surgeon.
2. Two letters of recommendation from institution where s/he works currently
3. Sponsorship letter form government
4. Applicant should score 70 and above on the entrance exam
5. The applicant need to submit CV, all credentials and one page interim Portfolio to clarify why s/he is interested to apply for Endocrine and Breast fellowship, expectation as an HPB fellow and what can s/he can contribute for the development of the program in terms of academics, research and patient care.
6. NGAT exam pass mark as per the national regulations
7. Based on the College’s admission capacity the program will admit the highest scoring candidates who achieve 70% or above and meet all the academic and non-academic requirements.
Application will be from December 29, 2025 to January 9, 2026 to the department office (3rd floor at old building).
Entrance exam will be on January 12, 2026.
Exam
● Reflective interim portfolio 20% (1 page)
● Written Exam (30%)
● Year of service (20%)
● Interview (
Call for Application
St Paul’s Hospital Millennium Medical College, Department of Surgery planned to enroll fellow in Vascular and Endovascular Surgery fellowship program. So it is to invite interested surgeons to apply for the program.
Eligibility:
1. At least 2 years of service as a general surgeon.
2. Two letters of recommendation from institution where s/he works currently
3. Sponsorship letter form government
4. Applicant should score 70 and above on the entrance exam
5. The applicant need to submit CV, all credentials and one page interim Portfolio to clarify why s/he is interested to apply for Endocrine and Breast fellowship, expectation as an HPB fellow and what can s/he can contribute for the development of the program in terms of academics, research and patient care.
6. NGAT exam pass mark as per the national regulations
7. Based on the College’s admission capacity the program will admit the highest scoring candidates who achieve 70% or above and meet all the academic and non-academic requirements.
Application will be from December 29, 2025 to January 9, 2026 to the department office (3rd floor at old building).
Entrance exam will be on January 12, 2026.
Exam
● Reflective interim portfolio 20% (1 page)
● Written Exam (30%)
● Year of service (20%)
● Interview (
Parathyroid cancer: one of the rare cancer worldwide treated at SPHMMC
St Paul’s Hospital Millennium Medical College (SPHMMC) reports that a 40-year-old woman from Addis Ababa has been successfully treated for parathyroid cancer, one of the rarest cancers worldwide.
Parathyroid cancer affects only 3.5 to 7 people per 10 million annually, representing less than 1% of primary hyperparathyroidism cases and approximately 0.005% of all cancers globally. Its rarity makes diagnosis and treatment particularly challenging. Precise data on parathyroid cancer incidence in the Ethiopian population is not readily available and has not been formally recorded.
The patient underwent specialised surgery at SPHMMC, led by Dr Yishak Suga, Breast and Endocrine Surgery sub-specialist, with the support of two trainee surgeons. The procedure was successful, and the patient is currently in good health.
Dr Yishak highlighted that early diagnosis and access to specialised surgical care are critical in managing rare conditions such as parathyroid cancer. He also noted that this case reflects SPHMMC’s growing expertise and capacity in advanced endocrine surgery.
(In the photo, the lead surgeon, Dr. Yishak, is at the center, with Dr. Geremew, the fellow, on the right, and Dr. Sisay on the left.)
St Paul’s Hospital Millennium Medical College (SPHMMC) reports that a 40-year-old woman from Addis Ababa has been successfully treated for parathyroid cancer, one of the rarest cancers worldwide.
Parathyroid cancer affects only 3.5 to 7 people per 10 million annually, representing less than 1% of primary hyperparathyroidism cases and approximately 0.005% of all cancers globally. Its rarity makes diagnosis and treatment particularly challenging. Precise data on parathyroid cancer incidence in the Ethiopian population is not readily available and has not been formally recorded.
The patient underwent specialised surgery at SPHMMC, led by Dr Yishak Suga, Breast and Endocrine Surgery sub-specialist, with the support of two trainee surgeons. The procedure was successful, and the patient is currently in good health.
Dr Yishak highlighted that early diagnosis and access to specialised surgical care are critical in managing rare conditions such as parathyroid cancer. He also noted that this case reflects SPHMMC’s growing expertise and capacity in advanced endocrine surgery.
(In the photo, the lead surgeon, Dr. Yishak, is at the center, with Dr. Geremew, the fellow, on the right, and Dr. Sisay on the left.)
የፓራታይሮይድ ካንሰር
የፓራታይሮይድ ካንሰር እጅግ አልፎ አልፎ የሚገኝ የኤንዶክራይን ካንሰር አይነት ሲሆን፣ ከመጀመሪያ ደረጃ የፓራታይሮይድ በሽታ (primary hyperparathyroidism) መካከል ከ1% በታች ይሆናል። ይህ ካንሰር ከፓራታይሮይድ ግላንዶች ይመነጫል፤ እነዚህም በአካል ውስጥ የካልሲየም መጠንን በፓራታይሮይድ ሆርሞን (PTH) በመመራት የሚቆጣጠሩ አነስተኛ የኤንዶክራይን አካላት ናቸው።
የፓራታይሮይድ ካንሰር ብዙ ጊዜ በራሱ እብጠት ሳይሆን በሚያስከትለው ከባድ ፓራታይሮይድ ቅመም መብዛት ይገለጣል። ታካሚዎች እጅግ ከፍ ያለ የደም ካልሲየም እና PTH መጠን ሊኖራቸው ይችላል፣ ይህም የአጥንት ህመም፣ ስብራት፣ የኩላሊት ጠጠር፣ የጡንቻ ድካም፣ የአእምሮ ለውጦች እና የአንጀት ችግር እንዲታዩ ያደርጋል። ከተለመዱ የፓራታይሮይድ እብጠቶች በተለየ፣ የፓራታይሮይድ ካንሰር በአንገት ላይ የሚታይ እብጠት፣ የድምፅ ነርቭ (recurrent laryngeal nerve) መጎዳት ሊታይበት ይችላል።
ምርመራው አስቸጋሪ ሲሆን፣ ከቀዶ ጥገና በፊት የፓራታይሮይድ ካንሰርን መለየት አስቸጋሪ ነው። የምስል ምርመራዎች እብጠቱን ለመፈለግ ይረዳሉ፣ ነገር ግን ካንሰር መሆኑን መለየት ብቻቸውን አይችሉም። የመጨረሻ ምርመራ ብዙውን ጊዜ ከቀዶ ጥገና በኋላ በፓቶሎጂ ላይ ይመሰረታል።
ዋና የሕክምና መንገድ ቀዶ ጥገና ነው። እብጠቱን ከተጎዳው ፓራታይሮይድ ግላንድ እና ከአጎራባች ክፍሎች ጋር በአንድነት (en bloc resection) ማስወገድ ለፈውስ ከፍተኛ እድል ይሰጣል። ከሌሎች ብዙ ካንሰሮች በተለየ፣ የፓራታይሮይድ ካንሰር ለኬሞቴራፒ እና ራዲዮቴራፒ ዝቅተኛ ምላሽ ይሰጣል፤ ስለዚህ ቀድሞ መለየት እና ሙሉ ቀዶ ጥገና እጅግ አስፈላጊ ናቸው።
በቅርቡ ይህን እጅግ አልፎ አልፎ የሚገኝ በሽታ የፓራታይሮይድ ቀዶ ሕክምና በተደረገላት ሴት ታካሚ ላይ ሰሞኑን ተገኝቷል፡፡ ዶር ይሰሀሐቅ እና ባልደረቦቻቸው ባደረጉላቸው ቀዶ ሕክምና ታካሚዋ በአሁኑ ሰዓት በመልካም ሁኔታ ይገኛሉ፡፡
ምንም እንኳን እጅግ አልፎ አልፎ ቢሆንም፣ የፓራታይሮይድ ካንሰር በጊዜው ካልታወቀ ወይም በተገቢ መንገድ ካልታከመ ከፍተኛ ጉዳት ሊያመጣ ይችላል።
ስለዚህ፣ በሕክምና ባለሙያዎች እና ለዜጎች በህመሙ ዙሪያ ግንዛቤ ማሳደግ አስፈላጊ ነው፤ ምክንያቱም ቀድሞ ምርመራ እና ተገቢ የቀዶ ሕክምና ና በዚህ እጅግ አልፎ አልፎ የሚገኝ ነገር ግን ከባድ በሽታ ውጤትን በከፍተኛ ሁኔታ ሊያሻሽል ይችላል።
የፓራታይሮይድ ካንሰር እጅግ አልፎ አልፎ የሚገኝ የኤንዶክራይን ካንሰር አይነት ሲሆን፣ ከመጀመሪያ ደረጃ የፓራታይሮይድ በሽታ (primary hyperparathyroidism) መካከል ከ1% በታች ይሆናል። ይህ ካንሰር ከፓራታይሮይድ ግላንዶች ይመነጫል፤ እነዚህም በአካል ውስጥ የካልሲየም መጠንን በፓራታይሮይድ ሆርሞን (PTH) በመመራት የሚቆጣጠሩ አነስተኛ የኤንዶክራይን አካላት ናቸው።
የፓራታይሮይድ ካንሰር ብዙ ጊዜ በራሱ እብጠት ሳይሆን በሚያስከትለው ከባድ ፓራታይሮይድ ቅመም መብዛት ይገለጣል። ታካሚዎች እጅግ ከፍ ያለ የደም ካልሲየም እና PTH መጠን ሊኖራቸው ይችላል፣ ይህም የአጥንት ህመም፣ ስብራት፣ የኩላሊት ጠጠር፣ የጡንቻ ድካም፣ የአእምሮ ለውጦች እና የአንጀት ችግር እንዲታዩ ያደርጋል። ከተለመዱ የፓራታይሮይድ እብጠቶች በተለየ፣ የፓራታይሮይድ ካንሰር በአንገት ላይ የሚታይ እብጠት፣ የድምፅ ነርቭ (recurrent laryngeal nerve) መጎዳት ሊታይበት ይችላል።
ምርመራው አስቸጋሪ ሲሆን፣ ከቀዶ ጥገና በፊት የፓራታይሮይድ ካንሰርን መለየት አስቸጋሪ ነው። የምስል ምርመራዎች እብጠቱን ለመፈለግ ይረዳሉ፣ ነገር ግን ካንሰር መሆኑን መለየት ብቻቸውን አይችሉም። የመጨረሻ ምርመራ ብዙውን ጊዜ ከቀዶ ጥገና በኋላ በፓቶሎጂ ላይ ይመሰረታል።
ዋና የሕክምና መንገድ ቀዶ ጥገና ነው። እብጠቱን ከተጎዳው ፓራታይሮይድ ግላንድ እና ከአጎራባች ክፍሎች ጋር በአንድነት (en bloc resection) ማስወገድ ለፈውስ ከፍተኛ እድል ይሰጣል። ከሌሎች ብዙ ካንሰሮች በተለየ፣ የፓራታይሮይድ ካንሰር ለኬሞቴራፒ እና ራዲዮቴራፒ ዝቅተኛ ምላሽ ይሰጣል፤ ስለዚህ ቀድሞ መለየት እና ሙሉ ቀዶ ጥገና እጅግ አስፈላጊ ናቸው።
በቅርቡ ይህን እጅግ አልፎ አልፎ የሚገኝ በሽታ የፓራታይሮይድ ቀዶ ሕክምና በተደረገላት ሴት ታካሚ ላይ ሰሞኑን ተገኝቷል፡፡ ዶር ይሰሀሐቅ እና ባልደረቦቻቸው ባደረጉላቸው ቀዶ ሕክምና ታካሚዋ በአሁኑ ሰዓት በመልካም ሁኔታ ይገኛሉ፡፡
ምንም እንኳን እጅግ አልፎ አልፎ ቢሆንም፣ የፓራታይሮይድ ካንሰር በጊዜው ካልታወቀ ወይም በተገቢ መንገድ ካልታከመ ከፍተኛ ጉዳት ሊያመጣ ይችላል።
ስለዚህ፣ በሕክምና ባለሙያዎች እና ለዜጎች በህመሙ ዙሪያ ግንዛቤ ማሳደግ አስፈላጊ ነው፤ ምክንያቱም ቀድሞ ምርመራ እና ተገቢ የቀዶ ሕክምና ና በዚህ እጅግ አልፎ አልፎ የሚገኝ ነገር ግን ከባድ በሽታ ውጤትን በከፍተኛ ሁኔታ ሊያሻሽል ይችላል።
Parathyroid Carcinoma: A Rare but Important Diagnosis
Parathyroid carcinoma is an exceptionally rare endocrine malignancy, accounting for less than 1% of all cases of primary hyperparathyroidism and for less than 0.005% of all malignancies worldwide. It arises from the parathyroid glands, which are small endocrine organs responsible for regulating calcium homeostasis through the secretion of parathyroid hormone (PTH).
Clinically, parathyroid cancer most often presents not because of the tumor itself, but due to severe hyperparathyroidism. Patients may develop markedly elevated serum calcium and PTH levels, leading to symptoms such as bone pain, fractures, kidney stones, muscle weakness, neurocognitive changes, and gastrointestinal complaints. Unlike benign parathyroid adenomas, parathyroid carcinoma may present with a palpable neck mass, recurrent laryngeal nerve involvement, or persistent disease after surgery.
Diagnosis is challenging and is rarely made preoperatively. Imaging studies help localize the lesion but cannot reliably distinguish carcinoma from benign disease. Definitive diagnosis is usually established postoperatively based on histopathological features such as capsular and vascular invasion, local tissue infiltration, or metastasis.
Surgical excision remains the cornerstone of treatment. En bloc resection of the tumor with the involved parathyroid gland and adjacent tissues offers the best chance for cure. Unlike many other cancers, parathyroid carcinoma responds poorly to chemotherapy and radiotherapy, making early recognition and complete surgical management critical.
We recently encountered this rare entity in a woman who underwent parathyroidectomy, highlighting the importance of maintaining a high index of suspicion in patients with severe or atypical hyperparathyroidism. Although uncommon, parathyroid carcinoma carries significant morbidity if unrecognized or inadequately treated.
Raising awareness among clinicians and the wider community is essential, as early diagnosis and appropriate surgical management can significantly improve outcomes in this rare but serious disease.
Parathyroid carcinoma is an exceptionally rare endocrine malignancy, accounting for less than 1% of all cases of primary hyperparathyroidism and for less than 0.005% of all malignancies worldwide. It arises from the parathyroid glands, which are small endocrine organs responsible for regulating calcium homeostasis through the secretion of parathyroid hormone (PTH).
Clinically, parathyroid cancer most often presents not because of the tumor itself, but due to severe hyperparathyroidism. Patients may develop markedly elevated serum calcium and PTH levels, leading to symptoms such as bone pain, fractures, kidney stones, muscle weakness, neurocognitive changes, and gastrointestinal complaints. Unlike benign parathyroid adenomas, parathyroid carcinoma may present with a palpable neck mass, recurrent laryngeal nerve involvement, or persistent disease after surgery.
Diagnosis is challenging and is rarely made preoperatively. Imaging studies help localize the lesion but cannot reliably distinguish carcinoma from benign disease. Definitive diagnosis is usually established postoperatively based on histopathological features such as capsular and vascular invasion, local tissue infiltration, or metastasis.
Surgical excision remains the cornerstone of treatment. En bloc resection of the tumor with the involved parathyroid gland and adjacent tissues offers the best chance for cure. Unlike many other cancers, parathyroid carcinoma responds poorly to chemotherapy and radiotherapy, making early recognition and complete surgical management critical.
We recently encountered this rare entity in a woman who underwent parathyroidectomy, highlighting the importance of maintaining a high index of suspicion in patients with severe or atypical hyperparathyroidism. Although uncommon, parathyroid carcinoma carries significant morbidity if unrecognized or inadequately treated.
Raising awareness among clinicians and the wider community is essential, as early diagnosis and appropriate surgical management can significantly improve outcomes in this rare but serious disease.
Happy New Year 2026 from SPHMMC
As we step into 2026, all of us at St Paul’s Hospital Millennium Medical College (SPHMMC) want to send our warmest wishes to our partners, friends, and everyone celebrating today.
The New Year is a time to pause and reflect—on caring for each other, on kindness, and on the power of working together. We are truly grateful for your support and for being part of this journey with us.
Wishing you a 2026 filled with good health, joy, and renewed energy as we work side by side to make a positive impact on the lives of those we serve.
As we step into 2026, all of us at St Paul’s Hospital Millennium Medical College (SPHMMC) want to send our warmest wishes to our partners, friends, and everyone celebrating today.
The New Year is a time to pause and reflect—on caring for each other, on kindness, and on the power of working together. We are truly grateful for your support and for being part of this journey with us.
Wishing you a 2026 filled with good health, joy, and renewed energy as we work side by side to make a positive impact on the lives of those we serve.